Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Halozyme Therapeutic (NQ: HALO )

37.31 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 37.31
Bid (Size) 30.03 (1)
Ask (Size) 48.00 (4)
Prev. Close 37.31
Today's Range 37.31 - 37.31
52wk Range 32.83 - 59.46
Shares Outstanding 142,334,900
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Medicare Negotiation Hammers Biotech Stocks Regeneron, Halozyme
It's still unclear whether CMS will include those drugs in its negotiation list. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
 
Via Benzinga

Performance

YTD
-32.32%
-32.32%
1 Month
-22.25%
-22.25%
3 Month
-34.52%
-34.52%
6 Month
-5.59%
-5.59%
1 Year
-7.24%
-7.24%

More News

Read More
The Latest Analyst Ratings for Halozyme Therapeutics
Via Benzinga
5 Analysts Have This to Say About Halozyme Therapeutics
Via Benzinga
Halozyme Therapeutics's Earnings: A Preview
Via Benzinga
Where Halozyme Therapeutics Stands With Analysts
Via Benzinga
5 Analysts Have This to Say About Halozyme Therapeutics
Via Benzinga
4 Analysts Have This to Say About Halozyme Therapeutics
Via Benzinga
Halozyme Therapeutics Shares Jump On Better Than Expected Annual Guidance
Via Benzinga
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
Via Investor's Business Daily
Nasdaq Rises Over 1%; CommVault Systems Shares Plummet
Via Benzinga
CommVault Systems, Halozyme Therapeutics And Other Big Stocks Moving Lower On Wednesday
Via Benzinga
Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
US Stocks Open Higher; Nasdaq Rises 60 Points
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022
Via Benzinga
Argenx's Flagship Neuromuscular Treatment For Subcutaneous Injection Goes Under Priority FDA Review
Via Benzinga
Amazon To $103? Plus Piper Sandler Predicts $300 For Illumina
Via Benzinga
Stock Market Rally Roars Higher On Cooling Inflation; Bitcoin, Meta, Tesla In Focus: Weekly Review
Via Investor's Business Daily
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Meta Platforms, Hilton Grand Vacations, D.R. Horton, And Some Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Argenx Seeks FDA Nod For Its Flagship Neuromuscular Treatment Formulated For Subcutaneous Injection
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.